Insights from 2023 ASCO® Annual Meeting

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Insights from 2023 ASCO® Annual Meeting

Breast
Hematology
Lung
GI
GU
GYN
Skin
Head and Neck
Sarcoma
CNS
Basic Science

Playback speed

10 seconds

ASCO® 2023 Insights: "Phase 1/2 TRIDENT-1 Trial - Intracranial and Systemic Efficacy of Repotrectinib in Advanced ROS1+ NSCLC & CNS Mets"

By Insights from 2023 ASCO® Annual Meeting FEATURING Jessica Lin

86 views

July 2, 2023

Comments 0

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Lung

ASCO® 2023 Summary: "Expert Discussion on New Treatment Options for …

Insights from 2023 ASCO® Annual Meeting

D. Carbone, B. Stiles

727 views

ASCO® 2023 Insights: "LUNAR Trial Key Learnings & Clinical Implicati…

Insights from 2023 ASCO® Annual Meeting

J. West

50 views

ASCO® 2023 Insights: "KEYNOTE-671 Trial Key Learnings & Clinical Imp…

Insights from 2023 ASCO® Annual Meeting

J. West

963 views

ASCO® 2023 Insights: "Phase 3 LATIFY Study - Ceralasertib + Durvalum…

Insights from 2023 ASCO® Annual Meeting

B. Besse

135 views

ASCO® 2023 Insights: "Resection of Localized Lung Cancer"

Insights from 2023 ASCO® Annual Meeting

J. Donington

148 views

ASCO® 2023 Insights: "A Phase 3 LAGOON Study - Lurbinectedin Alone o…

Insights from 2023 ASCO® Annual Meeting

B. Besse

150 views

ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Trametinib …

Insights from 2023 ASCO® Annual Meeting

V. Subbiah

1.2K views

ASCO® 2023 Insights: "SWOG S1929 Phase II Randomized Study - Mainten…

Insights from 2023 ASCO® Annual Meeting

N. Abdel Karim

54 views

ASCO® 2023 Insights: "Phase 1/2 TRIDENT-1 Trial - Intracranial and S…

Insights from 2023 ASCO® Annual Meeting

J. Lin

86 views

ASCO® 2023 Insights: "Randomized Phase 3 DeLLphi-304 Study - Tarlata…

Insights from 2023 ASCO® Annual Meeting

L. Paz-Ares

192 views

ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical Implicat…

Insights from 2023 ASCO® Annual Meeting

J. West

2.2K views

ASCO® 2023 Insights: "ctDNA Dynamics & Survival Outcomes in Pts with…

Insights from 2023 ASCO® Annual Meeting

N. Vokes

147 views

ASCO® 2023 Insights: "Phase 3 KEYNOTE-789 Study - Pemetrexed & Plati…

Insights from 2023 ASCO® Annual Meeting

J. Yang

246 views

ASCO® 2023 Insights: "Phase III, Double-Blinded, Randomized, Active-…

Insights from 2023 ASCO® Annual Meeting

L. Zhang

103 views

ASCO® 2023 Insights: "The Primary Endpoint Analysis of the Phase II …

Insights from 2023 ASCO® Annual Meeting

H. Akamatsu

250 views

ASCO® 2023 Insights: "New Therapies for SCLC"

Insights from 2023 ASCO® Annual Meeting

S. Lau

307 views

ASCO® 2023 Insights: "3-Year Results of the IFCT-1701 DICIPLE Phase …

Insights from 2023 ASCO® Annual Meeting

A. Toffart

497 views

ASCO® 2023 Insights: "ARC-7: Randomized Phase 2 Study of Domvanalima…

Insights from 2023 ASCO® Annual Meeting

M. Johnson

828 views

ASCO® 2023 Insights: "Final Survival Data From a Randomized Phase 2 …

Insights from 2023 ASCO® Annual Meeting

B. Henning Grønberg

83 views

ASCO® 2023 Insights: "CASPIAN Study Phase 3 Updates: The Prognostic …

Insights from 2023 ASCO® Annual Meeting

A. Ganti

241 views

Surgical Aspects in the Treatment of Locally Advanced NSCLC

Insights from 2023 ASCO® Annual Meeting

G. Veronesi

476 views